4.6 Article

Extracellular vesicles for precision medicine in prostate cancer-Is it ready for clinical translation?

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Medicine, General & Internal

Systematic review and meta-analysis of the diagnostic accuracy of prostate-specific antigen (PSA) for the detection of prostate cancer in symptomatic patients

Samuel W. D. Merriel et al.

Summary: The evidence currently available suggests that PSA is highly sensitive but poorly specific for detecting prostate cancer in symptomatic patients. However, limitations in study design and reference test reduce the certainty of this estimate. There is limited evidence regarding the performance of PSA in primary care, where most testing is done.

BMC MEDICINE (2022)

Review Oncology

Extracellular vesicles as a source of prostate cancer biomarkers in liquid biopsies: a decade of research

Manuel Ramirez-Garrastacho et al.

Summary: Research on analyzing extracellular vesicles for identifying biomarkers in various diseases, including prostate cancer, has gained attention in the past decade. Despite methodological challenges, new technologies such as nanotechnology offer promise for the future clinical utilization of extracellular vesicles as liquid biomarkers. The knowledge accumulated in the last decade provides a solid foundation for the development of liquid biopsy tests for prostate cancer, which is essential for advancing precision medicine in its treatment.

BRITISH JOURNAL OF CANCER (2022)

Article Oncology

Cancer extracellular vesicles, tumoroid models, and tumor microenvironment

Takanori Eguchi et al.

Summary: This review discusses tumor tissue culture and engineering platforms compatible with EV research, and summarizes the significant findings from combination experiments of 3D-tumoroids and EVs, as well as the applications of EV labeling technology.

SEMINARS IN CANCER BIOLOGY (2022)

Article Chemistry, Multidisciplinary

Microfluidic Size Exclusion Chromatography (μSEC) for Extracellular Vesicles and Plasma Protein Separation

Sheng Yuan Leong et al.

Summary: Extracellular vesicles are considered as next generation diagnostic biomarkers due to their disease-specific biomolecular cargoes and importance in cell-cell communications. This study presents a microfluidic platform for EV-protein fractionation using size exclusion chromatography. The device shows excellent performance in isolating EVs from biological samples and has been validated for clinical applications.
Article Urology & Nephrology

Event-free survival after radical prostatectomy according to prostate-specific membrane antigen-positron emission tomography and European Association of Urology biochemical recurrence risk groups

Matthew J. Roberts et al.

Summary: In patients with post-RP BCR, PSMA-PET findings and receipt of SRT predict event-free survival (EFS). Among patients receiving SRT, PSMA status combined with EAU risk grouping is the most predictive of EFS.

BJU INTERNATIONAL (2022)

Article Biochemistry & Molecular Biology

Migrasome biogenesis and functions

Shunbang Yu et al.

Summary: Migrasomes are newly discovered organelles produced by migrating cells, and their main functions include releasing signaling molecules, carrying damaged mitochondria, and lateral transfer of mRNA or proteins.

FEBS JOURNAL (2022)

Review Biochemistry & Molecular Biology

Single extracellular vesicle analysis for early cancer detection

Scott Ferguson et al.

Summary: Extracellular vesicles (EVs) are actively shed into the circulation from both cancer and host cells, and they are emerging as a frontrunner for early cancer detection. Analyzing single EVs using emerging technologies is crucial for early cancer detection.

TRENDS IN MOLECULAR MEDICINE (2022)

Article Multidisciplinary Sciences

Single-EV analysis (sEVA) of mutated proteins allows detection of stage 1 pancreatic cancer

Scott Ferguson et al.

Summary: This study shows that tumor cell-derived extracellular vesicles (EVs) have potential as circulating biomarkers for early cancer detection. Single-EV analysis (sEVA) technique improves diagnostic accuracy for pancreatic cancer (PDAC), even when the levels of KRAS(mut) and P53(mut) proteins are low.

SCIENCE ADVANCES (2022)

Article Oncology

A Model to Detect Significant Prostate Cancer Integrating Urinary Peptide and Extracellular Vesicle RNA Data

Shea P. O'Connell et al.

Summary: This study developed a urine test to predict the aggressiveness of prostate cancer and potentially reduce the need for biopsies. By combining clinical measurements, gene levels, and peptides in urine, this test improves the assessment accuracy and reliability for men with suspected prostate cancer.

CANCERS (2022)

Article Cell Biology

Analysis of extracellular vesicle DNA at the single-vesicle level by nano-flow cytometry

Haisheng Liu et al.

Summary: This study provides direct and conclusive experimental evidence for an in-depth understanding of how DNA is associated with extracellular vesicles (EVs). The study reveals that EVs carry naked DNA or DNA associated with non-vesicular entities. The quantity and distribution of EV-DNA vary depending on the cell type, with a high heterogeneity observed. The study also shows that external EV-DNA is mainly localized on smaller EVs, while internal EV-DNA is packaged inside larger EVs. The predominant form of EV-DNA is double-stranded DNA, and it is not associated with histone proteins.

JOURNAL OF EXTRACELLULAR VESICLES (2022)

Article Andrology

Urinary exosome-based androgen receptor-variant 7 detection in metastatic castration-resistant prostate cancer patients

Chao Wang et al.

Summary: This study investigated the non-invasive urine-derived exosomal AR-V7 analysis in mCRPC patients and found that positive AR-V7 was associated with resistance to abiraterone and poorer overall survival. The detection of urine-derived exosomal AR-V7 provides a sensitive and feasible clinical workflow for mCRPC patients.

TRANSLATIONAL ANDROLOGY AND UROLOGY (2022)

Review Urology & Nephrology

Using PSMA imaging for prognostication in localized and advanced prostate cancer

Matthew J. Roberts et al.

Summary: The use of PSMA-directed applications in prostate cancer management has rapidly evolved, providing new treatment pathways and insights into cancer biology. However, the prognostic implications of PSMA-PET have not been systematically studied yet, and further research is needed to determine its impact on oncological outcomes. Current data suggest an association between high PSMA expression and traditional prognostic factors and survival outcomes. However, PSMA-PET has poor sensitivity in detecting all metastases.

NATURE REVIEWS UROLOGY (2022)

Article Biology

An imaging flow cytometry-based methodology for the analysis of single extracellular vesicles in unprocessed human plasma

Wouter W. Woud et al.

Summary: This article presents a method to quantify and phenotype extracellular vesicles (EVs) in human plasma using imaging flow cytometry without prior isolation of EVs. The method eliminates selection bias or artifact introduced by EV isolation techniques and provides a framework for analyzing EVs in various experimental and potentially diagnostic settings.

COMMUNICATIONS BIOLOGY (2022)

Article Multidisciplinary Sciences

Urine stabilization and normalization strategies favor unbiased analysis of urinary EV content

Riccardo Vago et al.

Summary: Urine is an ideal source of non-invasive diagnostic markers, however, issues such as urine concentration variability and biases introduced in urine EV analysis restrict its full potential. This study evaluated methods to decrease biases and found that appropriate urine storage, optimal single-step EV purification method, and normalization method can enable accurate analysis of urine EV RNA.

SCIENTIFIC REPORTS (2022)

Review Endocrinology & Metabolism

Using human urinary extracellular vesicles to study physiological and pathophysiological states and regulation of the sodium chloride cotransporter

Aihua Wu et al.

Summary: The thiazide-sensitive sodium chloride cotransporter (NCC) plays a major role in electrolyte balance and blood pressure regulation. The renal-K+ switch mechanism, which links dietary potassium intake to NCC activity, may offer new targets for blood pressure control. However, the lack of human data to confirm findings from animal models is a hurdle for full acceptance of this model. Urinary extracellular vesicles (uEVs) have potential as biomarkers for studying renal physiology and pathology. Challenges include the diverse origins and dynamic molecular composition of uEVs.

FRONTIERS IN ENDOCRINOLOGY (2022)

Article Chemistry, Multidisciplinary

Calibration and standardization of extracellular vesicle measurements by flow cytometry for translational prostate cancer research

Yohan Kim et al.

Summary: Extracellular vesicles (EVs) are microscopic particles released naturally in biofluids and can serve as promising liquid biomarkers for human diseases. Flow cytometry is a popular method for detecting, characterizing, and determining the concentration of EVs. However, the limited awareness and utilization of standardization and calibration methods in the scientific community pose challenges for data reproducibility and inter-laboratory comparison. This study presents guidelines and best practices for flow cytometry in EV research, providing a systematic approach to evaluate performance and improve detection sensitivity for EVs.

NANOSCALE (2022)

Correction Radiology, Nuclear Medicine & Medical Imaging

68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer (Jul, 10.1007/s00259-020-04944-2, 2020)

Matthew J. Roberts et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Article Biochemistry & Molecular Biology

Detection of Prostate Cancer via IR Spectroscopic Analysis of Urinary Extracellular Vesicles: A Pilot Study

Xin-Le Yap et al.

Summary: The study successfully isolated medium EVs from the urine of prostate cancer patients, and using FTIR spectroscopy, it was found that the analysis of urinary EVs may offer a novel strategy for the development of a noninvasive additional test for prostate cancer screening, showing a potential for discriminating prostate cancer with a sensitivity of 59% and a specificity of 81%.

MEMBRANES (2021)

Review Urology & Nephrology

Dual-Tracer Positron-Emission Tomography Using Prostate-Specific Membrane Antigen and Fluorodeoxyglucose for Staging of Prostate Cancer: A Systematic Review

Stephen McGeorge et al.

Summary: PSMA PET is more accurate than conventional imaging for staging of intermediate- or high-risk prostate cancer, but some primary tumors have low PSMA ligand uptake. FDG PET can be used to further define disease extent in early-stage castrate-resistant PCa and may be beneficial for more accurate staging. Further studies are needed to determine the additive benefit of FDG PET and its potential indication for prognosis.

ADVANCES IN UROLOGY (2021)

Review Urology & Nephrology

Genomic and phenotypic heterogeneity in prostate cancer

Michael C. Haffner et al.

Summary: Prostate cancer is heterogeneous, with primary tumors being multifocal and metastatic tumors potentially originating from a single clone but exhibiting subclonal heterogeneity at the genomic, epigenetic, and phenotypic levels. The complex heterogeneous constellation of molecular alterations poses challenges for diagnosis and treatment of prostate cancer.

NATURE REVIEWS UROLOGY (2021)

Article Oncology

Androgen receptor gain in circulating free DNA and splicing variant 7 in exosomes predict clinical outcome in CRPC patients treated with abiraterone and enzalutamide

M. Del Re et al.

Summary: This study demonstrates that detecting AR variants in liquid biopsy can predict the clinical efficacy of AR signaling inhibitors in mCRPC patients. The presence of AR-V7 positivity and AR gain is significantly correlated with survival time in patients.

PROSTATE CANCER AND PROSTATIC DISEASES (2021)

Article Biochemistry & Molecular Biology

Single Extracellular Vesicle Analysis Performed by Imaging Flow Cytometry and Nanoparticle Tracking Analysis Evaluate the Accuracy of Urinary Extracellular Vesicle Preparation Techniques Differently

Marvin Droste et al.

Summary: Small extracellular vesicles isolated from urine (uEVs) are considered potential biomarkers, with different preparation strategies available. Analysis using nanoparticle tracking analysis (NTA), Western blot, and imaging flow cytometry (IFCM) showed that urine mainly contains CD9(+) sEV population, storage temperature affects CD9(+) sEV recovery, and challenges the reliability of traditional NTA for evaluating EV preparation methods.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Veterinary Sciences

Exploiting Microfluidics for Extracellular Vesicle Isolation and Characterization: Potential Use for Standardized Embryo Quality Assessment

Bahram Talebjedi et al.

Summary: In recent decades, research on extracellular vesicles (EVs) has grown significantly, particularly in their role in cellular communication and potential as biomarkers of health and disease. However, the importance of embryonic EVs is still limited due to small sample volumes, low EV concentrations, and complex isolation procedures. The use of microfluidics technologies shows promise in optimizing the isolation and characterization of embryonic EVs.

FRONTIERS IN VETERINARY SCIENCE (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Cell Biology

Supermeres are functional extracellular nanoparticles replete with disease biomarkers and therapeutic targets

Qin Zhang et al.

Summary: Supermeres are a distinct type of extracellular nanoparticles that exhibit unique biological and functional properties, with a different protein and RNA composition from small extracellular vesicles and exomeres. They are enriched with cargo involved in multiple cancers, Alzheimer's disease, and cardiovascular disease, and have specific functions in vivo, suggesting their potential as circulating biomarkers and therapeutic targets.

NATURE CELL BIOLOGY (2021)

Article Biochemistry & Molecular Biology

YAP1 overexpression contributes to the development of enzalutamide resistance by induction of cancer stemness and lipid metabolism in prostate cancer

Hsiu-Chi Lee et al.

Summary: The study identified YAP1 as overexpressed in enzalutamide-resistant cells, with COUP-TFII mediating its induction by enzalutamide. Functional analyses showed that YAP1 positively regulates genes related to cancer stemness and lipid metabolism, and its inhibitor attenuates the growth of EnzaR cells. Furthermore, EnzaR-EVs were found to enhance cancer stemness, lipid metabolism and enzalutamide resistance in parental cells, suggesting YAP1 as a potential therapeutic target for prostate cancer.

ONCOGENE (2021)

Article Oncology

Clinical significance of STEAP1 extracellular vesicles in prostate cancer

Karan Khanna et al.

Summary: The study identified circulating STEAP1-positive extracellular vesicles (EVs) in the plasma of healthy males and prostate cancer patients. There was a significant increase in STEAP1-positive EVs in prostate cancer patient plasma, but no association with disease recurrence or overall survival was found. STEAP1 was also found elevated in prostate cancer tissue, with no significant association with recurrence or overall survival.

PROSTATE CANCER AND PROSTATIC DISEASES (2021)

Article Oncology

Prognostic Significance of Gene Expression and DNA Methylation Markers in Circulating Tumor Cells and Paired Plasma Derived Exosomes in Metastatic Castration Resistant Prostate Cancer

Martha Zavridou et al.

Summary: Liquid biopsy based on CTCs and ctDNA allows real-time monitoring of tumor progression and treatment efficacy. A study on gene expression and DNA methylation markers in CTCs and plasma-derived exosomes in metastatic prostate cancer patients revealed higher positivity in markers in CTCs compared to exosomes, correlating with overall survival.

CANCERS (2021)

Article Oncology

Large Extracellular Vesicle Characterization and Association with Circulating Tumor Cells in Metastatic Castrate Resistant Prostate Cancer

Anna S. Gerdtsson et al.

Summary: Non-invasive liquid biopsies are a promising approach for tumor diagnosis and monitoring, with a focus on large extracellular vesicles (LEVs) which may provide informative sources for diagnosis and prognosis due to their increased presence in aggressive cancers. This study introduces a method for parallel identification and molecular characterization of LEVs and circulating tumor cells (CTCs), demonstrating that analysis of LEVs can enhance the sensitivity of liquid biopsy assays. The identification of LEVs in liquid biopsies offers potential for more comprehensive assessment of disease states for precise diagnosis and monitoring.

CANCERS (2021)

Article Oncology

Cause of death during prostate cancer survivorship: A contemporary, US population-based analysis

Adam B. Weiner et al.

Summary: Causes of death during PCa survivorship vary by patient and tumor characteristics. Men with early-stage prostate cancer are 4-fold more likely to die of other causes, whereas those with advanced prostate cancer are at increased risk for several causes not related to prostate cancer in comparison with the general population. These findings can help guide physicians taking care of men with a diagnosis of prostate cancer.

CANCER (2021)

Article Oncology

Radium-223 Treatment Increases Immune Checkpoint Expression in Extracellular Vesicles from the Metastatic Prostate Cancer Bone Microenvironment

Ioulia Vardaki et al.

Summary: The study found specific molecular differences in exosomes under Radium-223 treatment that may reflect the overall survival of patients, suggesting potential for monitoring treatment response. Furthermore, immune-suppressors related to the efficacy of Radium-223 were detected in exosomal transcripts from patients, indicating the potential of ICT to enhance the efficacy of Radium-223.

CLINICAL CANCER RESEARCH (2021)

Review Oncology

Molecular Imaging in Primary Staging of Prostate Cancer Patients: Current Aspects and Future Trends

Reyhaneh Manafi-Farid et al.

Summary: Accurate primary staging is essential for all malignancies. Different morphological imaging modalities are used to evaluate prostate cancer. Despite advancements, invasive histopathologic evaluation remains the standard method for primary prostate cancer detection and staging. Functional imaging plays a crucial role and is increasingly accepted in prostate cancer management. Targeted imaging with specific radiotracers has evolved significantly, showing promising results in non-invasive staging of prostate cancer.

CANCERS (2021)

Article Oncology

Significant Inter- and Intralaboratory Variation in Gleason Grading of Prostate Cancer: A Nationwide Study of 35,258 Patients in The Netherlands

Rachel N. Flach et al.

Summary: Significant variation in prostate cancer grading was observed between and within Dutch pathology laboratories, which may impact treatment strategies and prognosis assessment of prostate cancer patients. Case-mix correction did not explain the variation, highlighting the need for better standardization of prostate cancer grading.

CANCERS (2021)

Article Oncology

A Multivariate Diagnostic Model Based on Urinary EpCAM-CD9-Positive Extracellular Vesicles for Prostate Cancer Diagnosis

Yibei Dai et al.

Summary: The multivariate diagnostic model based on uEV(EpCAM-CD9) showed excellent performance in distinguishing prostate cancer from controls, with enhanced sensitivity and specificity compared to traditional PSA testing. The model also outperformed PSA in the "gray zone" of PSA levels, demonstrating potential for improved patient selection for prostate biopsies.

FRONTIERS IN ONCOLOGY (2021)

Article Multidisciplinary Sciences

Identification of a novel non-invasive biological marker to overcome the shortcomings of PSA in diagnosis and risk stratification for prostate cancer: Initial prospective study of developmental endothelial locus-1 protein

Jae-Wook Chung et al.

Summary: This study found that Del-1 protein has potential value in the diagnosis and risk assessment of prostate cancer (PCa), with higher expression in PCa patients compared to benign patients. Del-1 protein levels increase with the stage and Gleason score of PCa, suggesting it can be a useful marker in collaboration with PSA for the diagnosis and risk stratification of PCa.

PLOS ONE (2021)

Article Oncology

Clinical use of the SelectMDx urinary-biomarker test with or without mpMRI in prostate cancer diagnosis: a prospective, multicenter study in biopsy-naive men

Rianne J. Hendriks et al.

Summary: This study evaluated the SelectMDx test as a tool to detect high-grade prostate cancer in biopsy-naive men, showing that it can avoid unnecessary biopsies in 38% of cases and minimize detection of low-grade PCa. The combination strategy with mpMRI showed the highest net benefit in clinical utility.

PROSTATE CANCER AND PROSTATIC DISEASES (2021)

Article Multidisciplinary Sciences

Novel, non-invasive markers for detecting therapy induced neuroendocrine differentiation in castration-resistant prostate cancer patients

Divya Bhagirath et al.

Summary: The study identified novel non-invasive exosomal/extracellular vesicle-based biomarkers for diagnosing neuroendocrine differentiation in advanced castration-resistant prostate cancer patients. These biomarkers, including a miRNA panel and TSP1, could potentially guide treatment decisions in a clinically challenging setting.

SCIENTIFIC REPORTS (2021)

Article Oncology

Molecular Profiling of Docetaxel-Resistant Prostate Cancer Cells Identifies Multiple Mechanisms of Therapeutic Resistance

Thiago S. Lima et al.

Summary: The study identifies potential mechanisms associated with the development of taxane drug resistance in prostate cancer. Targeting these mechanisms could potentially re-sensitize drug-resistant cancer cells to docetaxel treatment and extend the life-prolonging effects of the drug in men with metastatic castration-resistant prostate cancer.

CANCERS (2021)

Article Oncology

High-Throughput and Automated Acoustic Trapping of Extracellular Vesicles to Identify microRNAs With Diagnostic Potential for Prostate Cancer

Anson Ku et al.

Summary: The development of an acoustic trapping technology allows for automatic enrichment of EVs from clinical samples, enabling robust and disease-discriminatory small RNA sequencing for diagnostic purposes.

FRONTIERS IN ONCOLOGY (2021)

Review Andrology

Extracellular vesicles in prostate cancer: a narrative review

Koji Hatano et al.

Summary: Remarkable progress has been made in prostate cancer biomarker discovery using liquid biopsies, with EVs showing potential as biomarkers for diagnosis and disease progression prediction in prostate cancer. EVs play a role in tumor microenvironment development and cancer progression.

TRANSLATIONAL ANDROLOGY AND UROLOGY (2021)

Article Oncology

Caveolin-1-driven membrane remodelling regulates hnRNPK-mediated exosomal microRNA sorting in cancer

Harley Robinson et al.

Summary: The study reveals a novel mechanism in which non-caveolar CAV1 drives the loading of metastasis-promoting microRNAs into exosomes by regulating hnRNPK localization, with this process being modulated by the lipid environment of membranes. Knockdown of hnRNPK in prostate cancer cells impairs the ability of extracellular vesicles to induce osteoclastogenesis, indicating a potential role in bone metastasis. Additionally, elevated levels of hnRNPK in biofluid extracellular vesicles are associated with metastatic prostate and colorectal cancer.

CLINICAL AND TRANSLATIONAL MEDICINE (2021)

Review Biochemistry & Molecular Biology

Novel Strategies for Treating Castration-Resistant Prostate Cancer

David Ka-Wai Leung et al.

Summary: The management of castration-resistant prostate cancer has seen significant progress, with three novel hormonal agents showing survival benefits in non-metastatic patients and a wider range of management options being investigated for metastatic disease.

BIOMEDICINES (2021)

Review Health Care Sciences & Services

Blood-Derived Biomarkers of Diagnosis, Prognosis and Therapy Response in Prostate Cancer Patients

Katalin Balazs et al.

Summary: Prostate cancer is a common cancer in men, often discovered in advanced stages. Current screening methods have limitations and there is a need for more accurate liquid biopsy markers. By discussing circulating tumor cells, extracellular vesicles with microRNA content, as well as immune and inflammation-related markers in blood, better diagnosis and treatment prediction for prostate cancer can be achieved.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Review Oncology

Metabolic reprogramming in prostate cancer

Fahim Ahmad et al.

Summary: While low-risk localized prostate cancer has a good prognosis with effective treatments, metastatic prostate cancer remains incurable and treatment resistance is a major issue. Resistance is primarily driven by tumor heterogeneity, altered genetic signatures, and metabolic reprogramming enabling tumors to adapt to drugs. Understanding prostate cancer metabolism may offer insights into therapy-induced adaptive responses and more durable therapeutic outcomes.

BRITISH JOURNAL OF CANCER (2021)

Article Urology & Nephrology

External Validation and Addition of Prostate-specific Membrane Antigen Positron Emission Tomography to the Most Frequently Used Nomograms for the Prediction of Pelvic Lymph-node Metastases: an International Multicenter Study

Dennie Meijer et al.

Summary: The study evaluated the predictive performance of different nomograms for pelvic lymph-node metastatic disease in prostate cancer patients with the addition of PSMA-PET, demonstrating improved discriminative ability of the models with the inclusion of PSMA-PET and suggesting its potential clinical utility for patient prognosis.

EUROPEAN UROLOGY (2021)

Review Biochemistry & Molecular Biology

Extracellular Vesicles in Blood: Sources, Effects, and Applications

Ainhoa Alberro et al.

Summary: Extracellular vesicles (EVs) play a vital role in intercellular communication, transferring information between nearby or distant cells. Blood is a major source of EVs, containing various types of EVs. Blood-derived EVs have significant potential in disease diagnosis, treatment monitoring, and prognosis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biochemistry & Molecular Biology

A urine extracellular vesicle circRNA classifier for detection of high-grade prostate cancer in patients with prostate-specific antigen 2-10 ng/mL at initial biopsy

Ya-Di He et al.

Summary: This study aimed to identify a urine extracellular vesicle circRNA classifier for detecting high-grade prostate cancer, which demonstrated higher accuracy and predictiveness compared to standard risk calculators in three separate cohorts. The noninvasive and easily implemented assay could potentially improve the clinical workflow for PCa diagnosis.

MOLECULAR CANCER (2021)

Review Biochemical Research Methods

Using single-vesicle technologies to unravel the heterogeneity of extracellular vesicles

Bordanaba-Florit Guillermo et al.

Summary: Understanding the heterogeneity of extracellular vesicles is crucial for unraveling their functions, but it also poses challenges for their application in medical diagnosis and therapies.

NATURE PROTOCOLS (2021)

Review Urology & Nephrology

Molecular events in neuroendocrine prostate cancer development

Yong Wang et al.

Summary: Neuroendocrine prostate cancer mainly develops from adenocarcinoma following a period of androgen suppressive treatment, and patients have poor outcomes; understanding the molecular mechanisms behind its development will improve future targeted therapy options.

NATURE REVIEWS UROLOGY (2021)

Review Oncology

PIWI-interacting RNA in cancer: Molecular mechanisms and possible clinical implications

Chao Yuan et al.

Summary: PIWI-interacting RNA is a type of non-coding small RNA found primarily in mammalian germ cells, which cooperates with PIWI protein family to participate in germ cell development and maintain genomic stability. Abnormal expression of piRNAs is associated with various human cancers, potentially serving as oncogenes or tumor suppressors and providing new opportunities for cancer diagnosis, treatment, or prognosis monitoring.

ONCOLOGY REPORTS (2021)

Review Chemistry, Analytical

Multiplexed Prostate Cancer Companion Diagnostic Devices

Josephine Aidoo-Brown et al.

Summary: This review discusses recent research on using optical and electrochemical biosensor platforms for multiplexed detection of PCa protein biomarkers, aiming to improve the diagnostic, surveillance, and treatment management of prostate cancer patients, and the importance of converting research protocols into multiplex point-of-care testing devices for use in near-patient settings.

SENSORS (2021)

Review Cell Biology

Role of noncoding RNA in drug resistance of prostate cancer

Lifeng Ding et al.

Summary: Prostate cancer is a common form of cancer worldwide, and noncoding RNAs play important roles in drug resistance in this disease. Noncoding RNAs, such as miRNAs, lncRNAs, and circRNAs, participate in cellular processes and diseases, and have potential therapeutic applications in prostate cancer.

CELL DEATH & DISEASE (2021)

Article Multidisciplinary Sciences

Diagnostic potential of serum extracellular vesicles expressing prostate-specific membrane antigen in urologic malignancies

Kyojiro Kawakami et al.

Summary: The study developed a sandwich ELISA for detection of PSMA-EVs using highly-purified EVs isolated from serum by Tim4. Results suggest that PSMA-EVs may be useful for diagnosing and monitoring not only PC but also RCC and possibly other hypervascular solid tumors.

SCIENTIFIC REPORTS (2021)

Review Oncology

Extracellular Vesicles in Advanced Prostate Cancer: Tools to Predict and Thwart Therapeutic Resistance

Carolina Saldana et al.

Summary: This review highlights the role of extracellular vesicles in therapeutic resistance of advanced prostate cancer and their potential for discovering predictive biomarkers to improve treatment outcomes.

CANCERS (2021)

Review Oncology

Role of Metastasis-Related microRNAs in Prostate Cancer Progression and Treatment

Su Jung Oh-Hohenhorst et al.

Summary: In this review, the dual roles of microRNAs in promoting and suppressing metastasis in prostate cancer are summarized, focusing on their impact on invasion, migration, and epithelial-to-mesenchymal transition. MicroRNAs have the potential to serve as therapeutic targets for metastatic prostate cancer and as biomarkers for metastasis and therapeutic response.

CANCERS (2021)

Article Cell Biology

Establishment of a simplified dichotomic size-exclusion chromatography for isolating extracellular vesicles toward clinical applications

Jiahui Guo et al.

Summary: The study established a simplified SEC method and compared different resins for EV isolation. By increasing column bed volumes and optimizing operations, the resolution and purity of EVs were improved. A dichotomic SEC method requiring only two bulk elutions was developed for efficient EV and protein separation from complex samples.

JOURNAL OF EXTRACELLULAR VESICLES (2021)

Article Oncology

Detection of Recurrent Prostate Cancer Using Prostate-specific Membrane Antigen Positron Emission Tomography in Patients not Meeting the Phoenix Criteria for Biochemical Recurrence After Curative Radiotherapy

Bernard H. E. Jansen et al.

Summary: This study reviewed 315 patients who underwent PSMA-PET scans after curative radiotherapy, revealing frequent detection of metastatic PCa even in patients below the Phoenix PSA threshold. This suggests a need for re-evaluation of the current diagnostic criteria for recurrent PCa after radiotherapy.

EUROPEAN UROLOGY ONCOLOGY (2021)

Review Urology & Nephrology

Blood and urine biomarkers in prostate cancer: Are we ready for reflex testing in men with an elevated prostate-specific antigen?

Edward K. Chang et al.

Summary: There is no consensus on the role of biomarkers in determining the utility of prostate biopsy in men with elevated PSA. The existing biomarker tests show roughly equivalent predictive accuracy, but are not substantial enough to justify reflexive use after an elevated PSA.

ASIAN JOURNAL OF UROLOGY (2021)

Article Oncology

Consensus on Treatment and Follow-Up for Biochemical Recurrence in Castration-Sensitive Prostate Cancer: A Report From the First Global Prostate Cancer Consensus Conference for Developing Countries

Fernando S. M. Monteiro et al.

Summary: The majority of clinicians in developing countries with limited resources use similar cutoff points and selection criteria to manage patients treated for biochemically recurrent castration-sensitive PCa.

JCO GLOBAL ONCOLOGY (2021)

Article Oncology

Changes in phospholipid metabolism in exosomes of hormone-sensitive and hormone-resistant prostate cancer cells

Xianlin Yi et al.

Summary: The study reveals differences in lipid metabolism in exosomes of hormone-sensitive and hormone-resistant prostate cancer cells, indicating potential for lipid-based biomarker screening. Phospholipids show varying compositions in exosomes from different cells, highlighting the importance of phosphatidylcholine and lysophosphatidylcholine in hormone-sensitive prostate cancer. Targeting lysophosphatidylcholine, autophagy, and ferroptosis pathways may offer new therapeutic strategies. The modified PEG precipitation technique shows promise for isolating prostate cancer cell exosomes for cancer screening.

JOURNAL OF CANCER (2021)

Article Medicine, Research & Experimental

Discovery of extracellular vesicles derived miR-181a-5p in patient's serum as an indicator for bone-metastatic prostate cancer

Yanqing Wang et al.

Summary: The study identified miR-181a-5p as a potential diagnostic biomarker for bone-metastatic prostate cancer in EVs from patient's serum, with significantly upregulated expression in bone metastatic groups compared to non-bone metastatic groups. Logistic regression and AUC analysis confirmed miR-181a-5p as the best biomarker for diagnosing both prostate cancer and bone metastatic prostate cancer.

THERANOSTICS (2021)

Article Pharmacology & Pharmacy

Preserving extracellular vesicles for biomedical applications: consideration of storage stability before and after isolation

Fumin Yuan et al.

Summary: Extracellular vesicles (EVs) are nanovesicles released by various cell types, known for their potent biological activities. While -80 degrees C is considered as the most favorable condition for storage, challenges remain in understanding the impact of storage conditions on EVs, indicating further research is needed.

DRUG DELIVERY (2021)

Article Biochemistry & Molecular Biology

The role of actinin-4 (ACTN4) in exosomes as a potential novel therapeutic target in castration-resistant prostate cancer

Yu Ishizuya et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)

Review Biochemistry & Molecular Biology

Exosome Composition and Seminal Plasma Proteome: A Promising Source of Biomarkers of Male Infertility

Luz Candenas et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Biochemistry & Molecular Biology

A Review of Exosomal Isolation Methods: Is Size Exclusion Chromatography the Best Option?

Karim Sidhom et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Medicine, General & Internal

Fifteen year quality of life outcomes in men with localised prostate cancer: population based Australian prospective study

Carolyn G. Mazariego et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Review Biochemistry & Molecular Biology

Immunocapture-based ELISA to characterize and quantify exosomes in both cell culture supernatants and body fluids

Mariantonia Logozzi et al.

EXTRACELLULAR VESICLES (2020)

Article Biochemical Research Methods

Microfluidic Raman biochip detection of exosomes: a promising tool for prostate cancer diagnosis

Yanlin Wang et al.

LAB ON A CHIP (2020)

Article Oncology

Accelerating precision medicine in metastatic prostate cancer

Joaquin Mateo et al.

NATURE CANCER (2020)

Article Urology & Nephrology

A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer

Jonas Hugosson et al.

EUROPEAN UROLOGY (2019)

News Item Medicine, General & Internal

Cancer survival data emphasise importance of early diagnosis

Nigel Hawkes

BMJ-BRITISH MEDICAL JOURNAL (2019)

Article Biochemistry & Molecular Biology

Exosome-derived miR-27a produced by PSC-27 cells contributes to prostate cancer chemoresistance through p53

Zhigang Cao et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)

Article Cell Biology

Transfer of Functional Cargo in Exomeres

Qin Zhang et al.

CELL REPORTS (2019)

Article Endocrinology & Metabolism

Plasma extracellular vesicles as phenotypic biomarkers in prostate cancer patients

France-Helene Joncas et al.

PROSTATE (2019)

Review Biochemistry & Molecular Biology

Mass spectrometry-based proteome profiling of extracellular vesicles and their roles in cancer biology

Raju Bandu et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2019)

Article Cell Biology

Precipitation-based extracellular vesicle isolation from rat plasma co-precipitate vesicle-free microRNAs

Jenni Karttunen et al.

JOURNAL OF EXTRACELLULAR VESICLES (2019)

Review Oncology

Epidemiology of Prostate Cancer

Prashanth Rawla

WORLD JOURNAL OF ONCOLOGY (2019)

Article Chemistry, Multidisciplinary

Multiplexed Profiling of Single Extracellular Vesicles

Kyungheon Lee et al.

ACS NANO (2018)

Article Oncology

microRNA-1246 Is an Exosomal Biomarker for Aggressive Prostate Cancer

Divya Bhagirath et al.

CANCER RESEARCH (2018)

Article Nanoscience & Nanotechnology

Nano-Vesicles are a Potential Tool to Monitor Therapeutic Efficacy of Carbon Ion Radiotherapy in Prostate Cancer

Qi Yu et al.

JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2018)

Review Oncology

Extracellular Vesicles in Prostate Cancer Carcinogenesis, Diagnosis, and Management

Virginie Vlaeminck-Guillem

FRONTIERS IN ONCOLOGY (2018)

Review Medicine, General & Internal

Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis

Dragan Ilic et al.

BMJ-BRITISH MEDICAL JOURNAL (2018)

Article Cell Biology

Large extracellular vesicles carry most of the tumour DNA circulating in prostate cancer patient plasma

Tatyana Vagner et al.

JOURNAL OF EXTRACELLULAR VESICLES (2018)

Review Urology & Nephrology

Biochemical recurrence after radical prostatectomy: what does it mean?

Rafael Tourinho-Barbosa et al.

INTERNATIONAL BRAZ J UROL (2018)

Review Biochemistry & Molecular Biology

Current knowledge on exosome biogenesis and release

Nina Pettersen Hessvik et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2018)

Article Biophysics

Atomic force microscopy analysis of extracellular vesicles

P. Parisse et al.

EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS (2017)

Article Oncology

Molecular lipid species in urinary exosomes as potential prostate cancer biomarkers

Tore Skotland et al.

EUROPEAN JOURNAL OF CANCER (2017)

Review Medicine, General & Internal

The Diagnosis and Treatment of Prostate Cancer A Review

Mark S. Litwin et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)

Review Oncology

Prognostic and predictive biomarkers in prostate cancer: latest evidence and clinical implications

Naoki Terada et al.

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2017)

Article Multidisciplinary Sciences

Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer

Kazutoshi Fujita et al.

SCIENTIFIC REPORTS (2017)

Review Pharmacology & Pharmacy

Tissue-based biomarkers in prostate cancer

Timothy N. Clinton et al.

EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT (2017)

Review Cardiac & Cardiovascular Systems

Methodological Guidelines to Study Extracellular Vesicles

Frank A. W. Coumans et al.

CIRCULATION RESEARCH (2017)

Review Oncology

Deciphering the function of non-coding RNAs in prostate cancer

Joao Ramalho-Carvalho et al.

CANCER AND METASTASIS REVIEWS (2016)

Article Urology & Nephrology

Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment

Scott A. Tomlins et al.

EUROPEAN UROLOGY (2016)

Review Biochemical Research Methods

Current state of the art for enhancing urine biomarker discovery

Michael Harpole et al.

EXPERT REVIEW OF PROTEOMICS (2016)

Article Chemistry, Multidisciplinary

Acoustic Purification of Extracellular Microvesicles

Kyungheon Lee et al.

ACS NANO (2015)

Review Oncology

Androgen deprivation of prostate cancer: Leading to a therapeutic dead end

Arndt Katzenwadel et al.

CANCER LETTERS (2015)

Article Multidisciplinary Sciences

Tumour exosome integrins determine organotropic metastasis

Ayuko Hoshino et al.

NATURE (2015)

Article Cell Biology

High-speed centrifugation induces aggregation of extracellular vesicles

Romain Linares et al.

JOURNAL OF EXTRACELLULAR VESICLES (2015)

Review Urology & Nephrology

Early Salvage Radiotherapy Following Radical Prostatectomy

David Pfister et al.

EUROPEAN UROLOGY (2014)

Review Pathology

Progensa™ PCA3 test for prostate cancer

Xavier Durand et al.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2011)

Article Genetics & Heredity

The effects of male aging on semen quality, sperm DNA fragmentation and chromosomal abnormalities in an infertile population

Sonia Brahem et al.

JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2011)

Article Medicine, General & Internal

Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer

Lionel L. Banez et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)